If increased TREK-2 protein levels require De novo synthesis of TREK-2, then inhibitors of protein synthesis should obviate differences in TREK-2 protein levels between control astrocytes and astrocytes exposed to hypoxia/hypoglycemia. This evidence concerns the gene KCNK10 and Hypoglycemia.